Recent Posts
- Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents.
- Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.
- The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.
- Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.
- ABA Intake Automation Found Its Market by Accident: Carelu Was Built to Qualify Sales Leads for Contractors, Then a Cold LinkedIn Message Pointed It Toward Autism Care.
Recent Comments
No comments to show.